SARS-CoV-2 Mpro-IN-35
SARS-CoV-2 Mpro-IN-35 (compound 14) is a SARS-CoV-2 Mpro inhibitor. SARS-CoV-2 Mpro-IN-35 can be used for the research of SARS-CoV-2 virus[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
ClC1=CN=C(C2(C)CCN(CC(N3C[C@@](C4)(C5=CC=C(Cl)C(Cl)=C5)[C@@]4([H])C3)=O)CC2)S1
Molecular Formula
C22H24Cl3N3OS
Molecular Weight
484.87
References & Citations
[1]Wilders H, et al. Expedited SARS-CoV-2 Main Protease Inhibitor Discovery through Modular 'Direct-to-Biology' Screening. Angew Chem Int Ed Engl. 2024 Dec 4:e202418314.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
156366-01 10 µg
Platelet Activating Factor Acetylhydrolase Ib3 (PAFAH1B3) Recombinant, Human
Ask
View Details 156366-02 50 µg
Platelet Activating Factor Acetylhydrolase Ib3 (PAFAH1B3) Recombinant, Human
Ask
View Details 156366-03 200 µg
Platelet Activating Factor Acetylhydrolase Ib3 (PAFAH1B3) Recombinant, Human
Ask
View Details 